The Venture Codex Logo

The Venture Codex

Overview

Expertise in bioengineering, molecular biology, and genomics.

Total Raised

$14 M

Rounds

7

Links

Verticals

Biopharma
Biotechnology
Genetics

Investment History

  1. Seed

    Mar 2026

    $9M

  2. Seed

    Mar 2024

    $3M

  3. Debt Financing

    Mar 2023

    $1M

  4. Seed

    May 2022

    $1M

  5. Grant

    Apr 2021

    $0M

Team

Daniel Alpern

Co-Founder, Chief Executive Officer & Board Member

Frederik Decouttere

Chief Executive Officer

Bart Deplancke

Co-Founder, Chief Scientific Officer, Scientific Advisor & Board Member

Riccardo Dainese

Co-Founder and Chief Commercial Officer